Michael A. Schwarzschild
Affiliations: | Neurology | Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States |
Google:
"Michael Schwarzschild"Mean distance: (not calculated yet)
Children
Sign in to add trainee| Nikolaus R. McFarland | post-doc | 2008-2010 | Massachusetts General Hospital and Harvard Medical School |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wyse RK, Isaacs T, Barker RA, et al. (2024) Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson's Disease: The International Linked Clinical Trials initiative. Journal of Parkinson's Disease |
| Ngo HKC, Le H, Ayer SJ, et al. (2024) Short-term lipopolysaccharide treatment leads to astrocyte activation in LRRK2 G2019S knock-in mice without loss of dopaminergic neurons. Research Square |
| Keavney JL, Mathur S, Schroeder K, et al. (2024) Perspectives of People At-Risk on Parkinson's Prevention Research. Journal of Parkinson's Disease |
| Sandoval-Insausti H, Flores-Torres MH, Bjornevik K, et al. (2024) Flavonoid intake and risk of Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry |
| Olsen A, Locascio J, Tuncali I, et al. (2023) Health phenome of Parkinson's patients reveals prominent mood-sleep cluster. Research Square |
| Flores-Torres MH, Bjornevik K, Zhang X, et al. (2023) Hair color, family history of melanoma, and the risk of Parkinson's disease: An analysis update. Parkinsonism & Related Disorders. 119: 105965 |
| Srivastava P, Nishiyama S, Zhou F, et al. (2023) Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson's Disease. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology |
| Xia N, Madore V, Albalakhi A, et al. (2023) Microglia-dependent neuroprotective effects of 4-octyl itaconate against rotenone-and MPP+-induced neurotoxicity in Parkinson's disease. Scientific Reports. 13: 15539 |
| Palacios N, Wilkinson J, Bjornevik K, et al. (2023) Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes. Annals of Neurology |
| Di Luca DG, Macklin EA, Hodgeman K, et al. (2023) Enrollment of Participants From Marginalized Racial and Ethnic Groups: A Comparative Assessment of the STEADY-PD III and SURE-PD3 Trials. Neurology. Clinical Practice. 13: e200113 |